Literature DB >> 22136608

Inadvertent exposures in children with peanut allergy.

Nha Uyen Nguyen-Luu1, Moshe Ben-Shoshan, Reza Alizadehfar, Lawrence Joseph, Laurie Harada, Mary Allen, Yvan St-Pierre, Ann Clarke.   

Abstract

OBJECTIVES: To determine the annual incidence, characterize the severity and management, and identify predictors of accidental exposure among a cohort of children with peanut allergy.
METHODS: From 2004 to November 2009, parents of Canadian children with a physician-confirmed peanut allergy completed entry and follow-up questionnaires about accidental exposures over the preceding year. Logistic regression analyses were used to examine potential predictors.
RESULTS: A total of 1411 children [61.3% boys, mean age 7.1 yr (SD, 3.9)] participated. When all children were included, regardless of length of observation, 266 accidental exposures occurred over 2227 patient-years, yielding an annual incidence rate of 11.9% (95% CI, 10.6-13.5). When all accidental exposures occurring after study entry and patients providing <1 yr of observation were excluded, 147 exposures occurred over a period of 1175 patient-years, yielding a rate of 12.5% (95% CI, 10.7-14.5). Only 21% of moderate and severe reactions were treated with epinephrine. Age ≥13 yr at study entry (OR, 2.33; 95% CI, 1.20-4.53) and a severe previous reaction to peanut (OR, 2.04; 95% CI, 1.44-2.91) were associated with an increased risk of accidental exposure, and increasing disease duration (OR, 0.88; 95% CI, 0.83-0.92) with a decreased risk.
CONCLUSION: The annual incidence rate of accidental exposure for children with peanut allergy is 12.5%. Children with a recent diagnosis and adolescents are at higher risk. Hence, education of allergic children and their families is crucial immediately after diagnosis and during adolescence. As many reactions were treated inappropriately, healthcare professionals require better education on anaphylaxis management.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 22136608     DOI: 10.1111/j.1399-3038.2011.01235.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  18 in total

Review 1.  Childcare and School Management Issues in Food Allergy.

Authors:  Angela Tsuang; Julie Wang
Journal:  Curr Allergy Asthma Rep       Date:  2016-11       Impact factor: 4.806

2. 

Authors:  Elissa M Abrams; Wade Watson
Journal:  Can Fam Physician       Date:  2017-10       Impact factor: 3.275

3.  Should peanut be allowed in schools? Yes.

Authors:  Elissa M Abrams; Wade Watson
Journal:  Can Fam Physician       Date:  2017-10       Impact factor: 3.275

4. 

Authors:  Elissa M Abrams; Wade Watson
Journal:  Can Fam Physician       Date:  2017-10       Impact factor: 3.275

5.  Should peanut be allowed in schools? No.

Authors:  Elissa M Abrams; Wade Watson
Journal:  Can Fam Physician       Date:  2017-10       Impact factor: 3.275

6.  HLA-DQB1*02 and DQB1*06:03P are associated with peanut allergy.

Authors:  Anne-Marie Madore; Vanessa T Vaillancourt; Yuka Asai; Reza Alizadehfar; Moshe Ben-Shoshan; Deborah L Michel; Anita L Kozyrskyj; Allan Becker; Moira Chan-Yeung; Ann E Clarke; Peter Hull; Denise Daley; Andrew J Sandford; Catherine Laprise
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

7.  B cells establish, but do not maintain, long-lived murine anti-peanut IgE(a).

Authors:  D M Moutsoglou; S C Dreskin
Journal:  Clin Exp Allergy       Date:  2016-04       Impact factor: 5.018

Review 8.  Next-Generation Approaches for the Treatment of Food Allergy.

Authors:  Jennifer A Dantzer; Robert A Wood
Journal:  Curr Allergy Asthma Rep       Date:  2019-01-28       Impact factor: 4.806

Review 9.  The evolving story of human leukocyte antigen and the immunogenetics of peanut allergy.

Authors:  Jonathan A Hemler; Elizabeth J Phillips; Simon A Mallal; Peggy L Kendall
Journal:  Ann Allergy Asthma Immunol       Date:  2015-10-27       Impact factor: 6.347

Review 10.  Oral and sublingual immunotherapy for food allergy: current progress and future directions.

Authors:  Timothy P Moran; Brian P Vickery; A Wesley Burks
Journal:  Curr Opin Immunol       Date:  2013-08-20       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.